JBT Marel (JBTM) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
1 Apr, 2026Executive summary
The 2026 Annual Meeting will be held virtually on May 14, 2026, for shareholders of record as of March 16, 2026.
Key proposals include re-election of ten directors, advisory approval of executive compensation, and ratification of PricewaterhouseCoopers LLP as auditor.
2025 marked a transformational year with the completed merger of John Bean Technologies Corporation and Marel hf., resulting in strong financial performance and operational integration.
The company reported $3.8 billion in 2025 revenue, significant synergy realization, and deleveraged its balance sheet to below 2.9x.
Voting matters and shareholder proposals
Shareholders will vote on re-electing ten directors for one-year terms, a non-binding say-on-pay resolution, and auditor ratification.
The board recommends voting in favor of all proposals.
Shareholders may submit proposals for the 2027 meeting by specified deadlines.
Board of directors and corporate governance
The board consists of ten members, nine of whom are independent, with an average tenure of six years.
Directors bring diverse expertise in finance, global business, manufacturing, and sustainability.
The board is declassified, with annual elections, and separates the roles of Chairman and CEO.
Stock ownership guidelines and a robust engagement program are in place.
Latest events from JBT Marel
- Merger creates a global food tech leader with strong synergies, closing by year end 2024.JBTM
Business Combination8 Jul 2026 - Q1 2025 revenue hit $854M, but one-time charges drove a $173M net loss; outlook cautious.JBTM
Q1 20258 Jul 2026 - $3.9B TTM revenue, 16.2% EBITDA margin, and strong recurring revenue drive growth and resilience.JBTM
Investor presentation31 May 2026 - All director nominees and proposals were approved, with no questions from stockholders.JBTM
AGM 202614 May 2026 - Q1 2026 saw 10% revenue growth, $45M net income, and strong Protein Solutions margin gains.JBTM
Q1 202612 May 2026 - 2025 saw record revenue and synergy gains, with 2026 set for further growth and margin expansion.JBTM
Q4 202511 Apr 2026 - Annual meeting to elect directors, approve pay, and ratify auditor, with board support.JBTM
Proxy filing1 Apr 2026 - Targeting 5–7% organic growth and >20% EBITDA margin by 2028 through digital integration.JBTM
Investor Day 202626 Mar 2026 - Merger forms a global food tech leader, targeting $125M+ synergies and closing by end-2024.JBTM
M&A Announcement3 Feb 2026